• Alerts
  • Drugs
    • ADHD Medications
    • Allergy Treatments
    • Antidepressants
    • Antipsychotics
    • Antibiotics
    • Antiseizure
    • Arthritis
    • Cancer Treatments
    • Cardiovascular
    • Diabetes Treatments
    • Dietary Supplements/Weight Loss
    • Erectile Dysfunction
    • Gastrointestinal
    • Hormone Therapy
    • Oral Contraception
    • Pain Relief
    • Respiratory
    • Skin Conditions
    • Sleep
  • Vaccines/Biologics
    • Blood Products
    • Genetic Testing
    • Tissues
    • Vaccines
  • Devices
    • 3D Printed
    • Autoinjectors
    • Brain Devices
    • Breast Implants
    • Cardiac Devices
    • Contraceptive Devices
    • Cyber Security
    • Home Health Devices
    • Hip Implants
    • Infusion Pumps
    • Respiratory Systems
    • Stents
    • Surgical Devices
    • Transvaginal Mesh
  • Tobacco
  • Resources
    • Product Safety and the FDA
    • Product Recalls
    • Product Liability Lawsuits
    • Questions For A Lawyer
    • Get Help
  • About Us

Brain Devices

    Covidien Recalls Pipeline and Alligator Brain Embolism Devices
    04/15/2014
    Covidien is voluntarily recalling some of its Pipeline and Alligator Brain Embolism devices after discovering a potentially lethal problem with the guidewires.  The guidewires are coated with a plastic designed to reduce friction.  The problem arises when the plastic coating on the guidewire delaminates and detaches from the devices, which could potentially lead to embolic occlusion with the risk of stroke and/or death.  32 Pipeline embolization devices and 621 Alligator retrieval devices are affected by this recall. Read more about Recalls.
    [1] Recall -- Firm Press Release, "Covidien Implements Voluntary Recall of its Pipeline(™) Embolization Device and Alligator(™) Retrieval Device," April 11, 2014.

Clinical Registry Evaluates Vercise Brain Stimulation System for Parkinson's Disease
04/15/2014
Boston Scientific has launched a clinical registry to evaluate the Vercise deep brain stimulation (DBS) system for Parkinson's disease.  Researchers will follow up to 300 patients implanted with the neurostimulator that targets areas of the brain associated with movement disorders.  The device is already sold in Europe, Israel, Australia, and parts of Latin America.  In the U.S., the device has investigational approval from the FDA , but is not yet approved for sale.
[1] Sarvestani, A. "Boston Scientific launches Parkinson's brain stim registry," Mass Device, April 14, 2014.

FDA Approves First Device to Prevent Migraines
03/13/2014
FDA has approved Cefaly, the first transcutaneous electrical nerve stimulation (TENS) device to prevent migraine pain.  Cefaly is a battery-powered device worn across the forehead that provides mild electrical stimulation to the trigeminal nerve, the nerve which is associated with migraines.  According to the device maker, STX-Med, the device is meant to be used once daily for 20 minutes.  Although no serious side effects were reported, the user may feel tingling or massaging sensation where the applied electrode touches the skin.

[1] U.S. National Library of Medicine, NIH, "First Device Approved to Prevent Migraines," HealthDay (March 12, 2014).


Picture

    Sign-up For Alerts

Submit

Picture
Get Help
If you have experienced adverse events or side effects from a medical device find help here.
Need help finding a medical or legal professional?  Email us at info@medwarn.org

Home
About Us
Get Alerts

Privacy Policy
Terms of Use
Get Help
© 2014 MedWarn LLC
Photo used under Creative Commons from steakpinball